Sat Kartar Life Balance Sheet Annual

BSE: - | NSE: SATKARTAR | ISIN: INE0NB801022 | Sector: Biotechnology & Drugs

117.00 +0.95 (0.82%)Updated : 08 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	84.85	63.74	21.75	14.71
Cash Equivalents	21.86	25.48	0.00	0.00
Other Liabilities Total	0.00	-	0.00	0.00
Long Term Debt	1.60	-	0.13	0.72
Common Stock Total	15.74	15.74	2.80	0.70
Other Current Assets Total	16.54	0.00	2.43	1.30
Total Assets	84.85	63.74	21.75	14.71
Current Portof LT Debt/ Capital Leases	0.82	0.84	0.17	1.33
Total Equity	67.60	51.50	9.43	3.27
Long Term Investments	0.52	0.82	1.05	0.00
Retained Earnings( Accumulated Deficit)	51.85	9.63	6.63	2.57
Total Common Shares Outstanding	1.57	1.57	1.57	1.57
Tangible Book Valueper Share Common Eq	39.67	32.71	5.99	2.08
Goodwill Net	0.64	-	-	-
Total Liabilities	17.25	12.24	12.32	11.44
Total Debt	2.42	5.92	1.78	3.75
Cashand Short Term Investments	21.86	30.70	2.54	0.68
Total Receivables Net	20.58	12.48	6.33	4.03
Accounts Receivable- Trade Net	14.47	5.98	2.31	0.09
Property/ Plant/ Equipment Total- Net	6.86	6.20	2.69	3.97
Minority Interest	0.00	-	-	-
Total Current Liabilities	15.65	10.25	11.80	9.01
Total Inventory	10.48	8.73	0.56	0.34
Accounts Payable	11.81	4.18	5.87	3.07
Other Currentliabilities Total	3.02	0.32	2.56	2.79
Total Long Term Debt	1.60	1.99	0.52	2.42
Intangibles Net	4.50	-	-	-
Other Long Term Assets Total	0.72	2.06	1.73	1.47
Note Receivable- Long Term	2.16	-	4.33	2.83
period Length	0.00	0.00	0.00	0.00
Total Current Assets	69.45	54.66	11.95	6.43
Accrued Expenses	-	1.82	2.11	1.83
Prepaid Expenses	-	2.75	0.10	0.09
Additional Paid- In Capital	-	26.13	0.00	0.00
Cash	-	5.22	2.52	0.65
Short Term Investments	-	0.00	0.02	0.02
Notes Payable/ Short Term Debt	-	3.09	1.09	0.00
Capital Lease Obligations	-	1.99	0.39	1.70
Accumulated Depreciation Total	-	-	-4.43	-3.26
Property/ Plant/ Equipment Total- Gross	-	-	7.12	7.23